Join Moss Adams and FLG partner Greg Curhan along with panelists from Moss Adams and Wilson Sonsini Goodrich & Rosati for a discussion on January 18th at 9:30 AM “Prepare Your Life Sciences Company for an IPO” to listen to a discussion about preparation strategies for helping a life sciences company achieve a successful IPO. This event is virtual and complimentary.

  • How to build out a support system of external professionals
  • Pitfalls and strategies for executives
  • Key reporting requirements
  • Controls for financial reporting, due diligence, and legal matters to address during preparation


Greg Curhan, Partner, FLG Partners

Greg joined FLG in 2020, with over 35 years of operational, financial, capital markets, and strategic advisory experience in various sectors including investment banking, medical devices, life sciences, internet, clean technology, and wealth management. He has raised equity and debt capital for both private and public companies, completed a successful IPO, and executed M&A transactions both acquiring and divesting companies. He has also served in CEO, president, and board of director capacities.

Stephen Fineberg, CPA, CIA, CFE, CISA, CITP, CRMA, Partner, Moss Adams

Steve has provided internal audit, SOX, forensic accounting, IT compliance, and management consulting services since 2003. He’s developed deep, relevant experience performing business process and IT control reviews. Steve’s substantial internal audit experience leading projects end-to-end across multiple industries in both business operations and information technology means he has advanced skills in automating business processes.

Sarah Ratra, CPA, Partner, Moss Adams

Sarah has practiced public accounting since 1999, primarily serving clients in the technology and life sciences industries, including software, internet, biotechnology, pharmaceutical, and medical device companies. Her expertise also includes working with venture funds and management companies focused on investment valuation and other complex accounting issues. She consults clients in the application and implementation of new accounting policies and technical guidance in compliance with SEC, SOX 404, and US GAAP requirements.

Karen Deschaine, JD, Partner, Wilson Sonsini Goodrich & Rosati

Karen represents clients in the life sciences sector, primarily in the biotechnology and therapeutics space. Over the course of 15-plus years, Karen has developed a sophisticated company-building corporate life sciences practice. She has handled private financings, public offerings, corporate governance matters, commercial transactions, strategic transactions, securities matters, and the general representation of public and private companies.